Back to all Programs

Past Event

Related Materials

Past Event

International Viral Hepatitis Elimination Meeting (IVHEM) 2016

Viral Hepatitis and Liver Disease

National perspectives in Europe - common themes and challenges | Angelos Hatzakis, MD, PhD, MSc

Viral Hepatitis and Liver Disease

National Programs - the Netherlands | Anouk Urbanus

Viral Hepatitis and Liver Disease

National Programs - Egypt | Wahid Doss, MD

Viral Hepatitis and Liver Disease

National Programs - Australia | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

Viral Hepatitis and Liver Disease

National Programs - US | John Ward, MD

Viral Hepatitis and Liver Disease

Session 1 Discussion panel

Viral Hepatitis and Liver Disease

Progress towards elimination in the Australian prison sector | Andrew Lloyd, MBBS, MD, FRACP, PhD

Viral Hepatitis and Liver Disease

Children & Pregnant Women | Manal El-Sayed, MD, PhD

Viral Hepatitis and Liver Disease

Session 2 Discussion panel

Viral Hepatitis and Liver Disease

WHO Guidelines and Policies of testing | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

Viral Hepatitis and Liver Disease

Progess in testing technologies | Dmytro Donchuk

Viral Hepatitis and Liver Disease

Challenges in Monitoring (POC) | Isabelle Andrieux-Meyer

Viral Hepatitis and Liver Disease

Global Injection Safety Campaign and Prevention Strategies | Arshad Altaf, MD, MBBS

Viral Hepatitis and Liver Disease

Creating awareness and sharing the knowledge | Anya Sarang

Viral Hepatitis and Liver Disease

Community and harm reduction response to infection and reinfection | Eberhard Schatz

Viral Hepatitis and Liver Disease

Session 4 Discussion panel

Viral Hepatitis and Liver Disease

Vaccine development and results | Andrea Cox, MD

Viral Hepatitis and Liver Disease

Minimising treatment duration and doses | Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

Role of generic drugs | Andrew Hill, MD

Viral Hepatitis and Liver Disease

Financial models for high- and low income countries | Pieter Walhof

Viral Hepatitis and Liver Disease

Building global capacity | Stefano Vella

Viral Hepatitis and Liver Disease

Session 5 Discussion panel